BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9288184)

  • 1. Effects of a new 5 alpha reductase inhibitor (epristeride) on human prostate cell cultures.
    Robinson EJ; Collins AT; Robson CN; Neal DE
    Prostate; 1997 Sep; 32(4):259-65. PubMed ID: 9288184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
    Wu SF; Sun HZ; Qi XD; Tu ZH
    Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
    Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
    Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible long-term toxicity of epristeride in beagle dogs.
    Sun ZY; Feng J; Qi XD; Wu HY; Zheng WJ; Tu ZH
    Toxicol Appl Pharmacol; 1999 Jan; 154(2):145-52. PubMed ID: 9925798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone regulation of human prostate in organ culture.
    Nevalainen MT; Härkönen PL; Valve EM; Ping W; Nurmi M; Martikainen PM
    Cancer Res; 1993 Nov; 53(21):5199-207. PubMed ID: 7693334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cultured rat prostatic epithelial cell growth by epristeride in vitro.
    Wu SF; Sun HZ; Tu ZH; Wu HY
    Acta Pharmacol Sin; 2001 Mar; 22(3):257-63. PubMed ID: 11742574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
    Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
    Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of testosterone 5 alpha-reductase: evidence for tissue-specific regulation of thromboxane A2 receptors.
    Higashiura K; Blaney B; Morgan E; Mathur RS; Halushka PV
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1386-91. PubMed ID: 8968363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
    Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
    Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of epristeride against benign prostatic hyperplasia.
    Sun ZY; Wu HY; Wang MY; Tu ZH
    Eur J Pharmacol; 1999 Apr; 371(2-3):227-33. PubMed ID: 10357260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats.
    Yasuda N; Fujino K; Shiraji T; Nambu F; Kondo K
    Jpn J Pharmacol; 1997 Jul; 74(3):243-52. PubMed ID: 9268084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of regrowth of prostatic glandular cells by epristeride.
    Qian LH; Wang XL; Tu ZH
    Acta Pharmacol Sin; 2001 Sep; 22(9):847-50. PubMed ID: 11749869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
    Berthaut I; Mestayer C; Portois MC; Cussenot O; Mowszowicz I
    Prostate; 1997 Aug; 32(3):155-63. PubMed ID: 9254894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.
    Hsieh JT; Chen SC; Yu HJ; Chang HC
    Prostate; 2011 Jul; 71(10):1115-21. PubMed ID: 21557276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation and differentiation of prostatic stromal cells.
    Niu Y; Xu Y; Zhang J; Bai J; Yang H; Ma T
    BJU Int; 2001 Mar; 87(4):386-93. PubMed ID: 11251536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.